Back to search

Article

New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes Treatment

2023-12-13

Abstract excerpt

Achieving glycemic control and sustaining functional pancreatic β-cell activity remains an unmet medical need in the treatment of type 2 diabetes mellitus (T2DM). Glucokinase activators (GKAs) constitute a class of anti-diabetic drugs designed to regulate blood sugar levels and enhance β-cell function in patients with diabetes. A significant progression in GKA development is underway to address the limitations of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37099c8d-1e8f-5dbe-88ed-57951936e4be
DOI
10.20944/preprints202312.0917.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes TreatmentDOI 10.20944/preprints202312.0917.v1
Select a neighboring publication to make it the new centre.